Drug Type Small molecule drug |
Synonyms NSC-88536, U-22550 |
Target |
Action modulators |
Mechanism AR modulators(Androgen Receptor modulators) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization- |
License Organization- |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC21H32O2 |
InChIKeyIVFYLRMMHVYGJH-PVPPCFLZSA-N |
CAS Registry17021-26-0 |
| KEGG | Wiki | ATC | Drug Bank |
|---|---|---|---|
| - | Calusterone | - |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Advanced breast cancer | Preclinical | - | - | 01 Jan 1977 |





